Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMISE: Progesterone and Enoxaparin in Recurrent Pregnancy Loss
NCT07796737Phase 3Not yet recruiting
- Sponsor
- General University Hospital in Prague
- Start
- Dec 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 3 trial of Crinone, enoxaparin in recurrent pregnancy loss (RPL), sponsored by General University Hospital in Prague. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
Crinoneenoxaparin
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT07796737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07796737.